A Revolutionary New Therapy for Obstructive Sleep Apnea (OSA)

June 20, 2012

OSA is a serious medical condition characterized by repetitive episodes of blockage of the airflow to the lungs during sleep. This is caused by the complete collapse of the airway and stoppage of airflow (known as apnea) or a reduction of airflow caused by a partial collapse of the airway (known as hypopnea). These breathing interruptions can cause a person to momentarily wake in order to resume normal breathing. For many sufferers this can happen dozens of times during the night and greatly affect the quality of sleep. OSA has been associated with a wide range of other health issues such as hypertension, diabetes, obesity, heart disease and stroke. Fortunately, successful treatment of OSA has been shown to reduce the risk of developing these associated health issues.

Provent® Sleep Apnea Therapy utilizes small, single-use adhesive devices that attach to the nostrils, providing an effective, FDA-cleared, nonsurgical treatment to reduce the effects of OSA. Provent Sleep Apnea Therapy has shown to be both SAFE and EFFECTIVE in 10 different clinical trials involving more than 750 people with OSA. Trial results have been published in international peer-reviewed journals including the medical journal Sleep. Provent Sleep Apnea Therapy is currently commercially available in the United States, Australia, New Zealand, Hong Kong and Canada.

In the months ahead, this blog will offer insight and experience from sleep physicians and healthcare professionals involved in sleep-disordered breathing, as well as patients who are benefiting from this technology. So check back often and join in the conversations.